FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to intensive care and resuscitation, and can be used for treating patients with a new coronavirus infection (COVID-19). Method involves intravenous introduction of a serotonin adipinate solution at rate of 10–30 mg/h to the patients with a new coronaviral infection COVID-19 with respiratory failure on respiratory support. Respiratory support is non-invasive lung ventilation, oxygen therapy; additionally, calcium nandroparin or enoxaparine are administered.
EFFECT: using the invention enables improving the oxygenating function of the lungs by normalizing smooth muscle function of the microcirculatory bed of the lungs and other organs, and thereby increasing gas exchange.
1 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IMPROVING OXYGENATING PULMONARY FUNCTION IN PATIENTS WITH RESPIRATIVE INSUFFICIENCY BEING UPON CONTROLLED VENTILATION | 2003 |
|
RU2245139C1 |
| METHOD OF DIAGNOSING IMPAIRMENT OF BLOOD OXYGENATION IN PROCESS OF ARTIFICIAL LUNG VENTILATION | 2011 |
|
RU2457781C1 |
| METHOD FOR OXYGEN THERAPY DURING SPONTANEOUS BREATHING IN CORONAVIRUS INFECTION | 2022 |
|
RU2787834C1 |
| METHOD FOR PREVENTING DECOMPENSATED RESPIRATORY FAILURE FOLLOWING RADICAL SURGICAL TREATMENT OF LUNG CANCER IN PATIENTS WITH SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2023 |
|
RU2829259C1 |
| METHOD FOR THE TREATMENT OF RESPIRATORY FAILURE AFTER ACUTE RESPIRATORY DISTRESS SYNDROME, REGARDLESS OF ETIOLOGY | 2022 |
|
RU2782103C1 |
| METHOD OF CHOOSING TACTICS FOR CORRECTING ACUTE RESPIRATORY FAILURE IN PATIENTS WITH COVID-19 | 2023 |
|
RU2807934C1 |
| METHOD FOR COVID-19 PNEUMONIA TREATMENT | 2020 |
|
RU2745535C1 |
| METHOD FOR CORRECTION OF OXYGENATING PULMONARY FUNCTION | 2011 |
|
RU2466748C1 |
| METHOD FOR IMPROVING CONTRACTILE MYOCARDIAL FUNCTION IN PATIENTS WITH ISCHEMIC CARDIAC DISEASE | 2002 |
|
RU2200551C1 |
| METHOD FOR PREDICTING THE LETHAL OUTCOME IN PATIENTS WITH SEVERE CoVID-19 | 2021 |
|
RU2780748C1 |
